摘要 |
<p>The present invention relates to novel oxazolidinone compounds of the general formula (I) where R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, Y<SUP>1</SUP>, Y<SUP>2</SUP>, Y<SUP>3</SUP>, and Z are as defined in the description; their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutical acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.</p> |